0000899243-19-018360.txt : 20190627
0000899243-19-018360.hdr.sgml : 20190627
20190627161731
ACCESSION NUMBER: 0000899243-19-018360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190617
FILED AS OF DATE: 20190627
DATE AS OF CHANGE: 20190627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krasnow Ronald A.
CENTRAL INDEX KEY: 0001591469
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 19925505
MAIL ADDRESS:
STREET 1: C/O RELYPSA, INC.
STREET 2: 700 SAGINAW DR.
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Menlo Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CARDINAL WAY, 2ND FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-486-1416
MAIL ADDRESS:
STREET 1: 200 CARDINAL WAY, 2ND FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-17
0
0001566044
Menlo Therapeutics Inc.
MNLO
0001591469
Krasnow Ronald A.
200 CARDINAL WAY, 2ND FLOOR
REDWOOD CITY
CA
94063
0
1
0
0
See Remarks
Stock Option
6.32
2019-06-17
4
A
0
130000
0.00
A
2029-06-17
Common Stock
130000
130000
D
The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.
General Counsel and Chief Compliance Officer
/s/ Ronald A. Krasnow
2019-06-27